Made by the makers of VIVAYZIO

A closer look at Nocturnal Continuity Dysregulation.

Learn how Elara Therapeutics defines NCD, including its symptoms, pathophysiology, and diagnostic profile.

A distinct clinical pattern

Nocturnal Continuity Dysregulation (NCD)

NCD is a neurophysiologic sleep disorder characterized by failure to maintain contiguous overnight sleep architecture despite successful sleep initiation.

Patients may describe “sleep that won’t stay assembled,” repeated overnight resets, and next-day cognitive drag that feels out of proportion to total hours in bed.

Core diagnostic features

  • At least 3 nights weekly of post-onset sleep fragmentation for 3 months or longer
  • Median return-to-sleep latency of at least 22 minutes after overnight awakening
  • Morning Cognitive Sealing Index score ≥18
  • Evidence of continuity-collapse phenotype on sleep history or partner report
Pathophysiology hypothesis

What may be happening overnight

Continuity gate instability

In NCD, the overnight “gate” that protects sleep from arousal spillover may remain permeable during vulnerable transition periods.

Micro-arousal amplification

Minor internal or environmental triggers may be magnified into full continuity breaks, particularly during N2-to-N3 handoff.

Incomplete morning sealing

Because restorative architecture never fully consolidates, patients awaken feeling mentally porous rather than restored.

Who may be affected

Common presentations of NCD

Adults 35–64
68%

of LANTERN participants were in peak work and caregiving years.

Women
57%

of enrolled participants identified as women.

Comorbid stress load
61%

reported elevated evening cognitive carryover despite normal sleep initiation.

Partner-noted awakenings
74%

were first recognized by a spouse or partner before self-report.

Differential framing

NCD is not the same as classic insomnia.

  • Primary challenge is overnight continuity, not necessarily initial sleep onset
  • Daytime impact includes recall lag, decision friction, and cognitive softness
  • Patients may underestimate severity because total time in bed appears adequate

Ask your healthcare provider about:

Frequency of overnight awakenings, time needed to return to sleep, next-day morning function, medication history, alcohol use, and partner-observed sleep fragmentation.

Site notice

Site notice

About this experience

This website is a satirical brand experience created for entertainment and storytelling purposes. SLUMBARA, Elara Therapeutics, and all related conditions, trial programs, claims, and product information presented here are fictional.

Important Safety Information: Slumbara may cause next-morning coordination changes, sleep-transition confusion, visual dimming upon waking, unusual calm urgency, and episodes of perceived environmental softness. Do not take with orexin antagonists, chronoactive sedatives, or while operating machinery.